Germany· DE-A57-3bf436fb6d41fef4
Virgan
A medicinal product containing ganciclovir, registered in Germany by Laboratoires Thea.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ganciclovir
- Manufacturer
- Laboratoires Thea
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ganciclovir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandCymeveneInPharm Sp. z o.o.
- United KingdomCymevene 250mg capsulesRoche Products Ltd
- United StatesganciclovirSlate Run Pharmaceuticals, LLC
- FinlandCymeveneCheplapharm Arzneimittel GmbH
- SpainCYMEVENE 500 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONCheplapharm Arzneimittel Gmbh
- SwedenCymevene 500 mg Pulver till koncentrat till infusionsvätska, lösningOrifarm AB
- CanadaCYTOVENECHEPLAPHARM ARZNEIMITTEL GMBH
- FranceCYMEVAN 500 mg, poudre pour solution à diluer pour perfusionCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Cymevene, Ganciclovir Oresund Pharma
- Belgium · Cymevene, Virgan
- Bulgaria · Ганцикловир Ромфарм
- Czechia · Cymevene, Virgan
- Denmark · Cymevene, Ganciclovir Oresund Pharma
- Spain · Cymevene, Ganciclovir Accord
- Finland · Cymevene, Ganciclovir Bioglan
- France · Cymevan, Ganciclovir Hikma
- United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
- Greece · Gancilen, Virgan
- Croatia · Cymevene
- Hungary · Cymevene, Ganciclovir Rompharm
- Ireland · Cymevene
- Italy · Citovirax, Ganciclovir Accord
- Luxembourg · Cymevene, Virgan
- Netherlands · Cymevene, Ganciclovir Sandoz
- Norway · Cymevene, Ganciclovir Bioglan
- Poland · Cymevene, Ganciclovir Accord
- Portugal · Cymevene, Ganciclovir Accord
- Romania · Ganciclovir Rompharm, Virgan
- Sweden · Cymevene, Ganciclovir Bioglan
- Slovakia · Cymevene
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cff0fb40-3df8-4d3a-8603-8991f0ad1747 GET /v1/drugs/cff0fb40-3df8-4d3a-8603-8991f0ad1747?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ganciclovir",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ganciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.